Table of contents

Original Articles

• Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer (1 July, 2008)

  A. Gadducci, R. Tana, G. Teti, G. Zanca, A. Fanucchi, A. R. Genazzani
• Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer (1 July, 2008)

  A. H.M.M. Arits, J. E.G.M. Stoot, A. A.M. Botterweck, F. J.M.E. Roumen, A. C. Voogd
• Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy (1 July, 2008)

  A. E. Bland, E. N. Everett, L. M. Pastore, W. A. Andersen, P. T. Taylor
• Discordant MRI/FDG- PET imaging for the diagnosis of borderline ovarian tumors (1 July, 2008)

  D. C. Jung, H. J. Choi, W. Ju, S. C. Kim, K-G. Choi
• Characteristics of recurrence in adult- type granulosa cell tumor (1 July, 2008)

  Y.-K. Lee, N.-H. Park, J. W. Kim, Y.-S. Song, S.-B. Kang, H.-P. Lee
• Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction (1 July, 2008)

  N. Sirisabya, Y. Li, A. Jaishuen, H. G. Zheng, D. M. Gershenson, J. J. Kavanagh
• Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma (1 July, 2008)

  Y. Liu, L. Chen, X. He, L. Fan, G. Yang, X. Chen, X. Lin, L. Du, Z. Li, H. Ye, Y. Mao, X. Zhao, Y. Wei
• Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer (1 July, 2008)

  X. L. Du, C. C. Sun, M. R. Milam, D. C. Bodurka, S. Fang
• Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3- kinase/Akt pathway (1 July, 2008)

  D. Lane, A. Cartier, C. Rancourt, A. PichÉ
• Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga- like toxin I (1 July, 2008)

  F. Wei, S. Cao, X. Ren, H. Liu, J. Yu, H. Li, X. Hao
• The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma (1 July, 2008)

  J. E. Palmer, L. J. Sant Cassia, C. J. Irwin, A. G. Morris, T. P. Rollason
• Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer (1 July, 2008)

  K. D. Steffensen, M. WaldstrØ M, U. Jeppesen, I. Brandslund, A. Jakobsen
• LINE- 1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer (1 July, 2008)

  J. Pattamadilok, N. Huapai, P. Rattanatanyong, A. Vasurattana, S. Triratanachat, D. Tresukosol, A. Mutirangura
• ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl (1 July, 2008)

  W. Xu, B. Cai, J. L. Chen, L. X. Li, J. R. Zhang, Y. Y. Sun, X. P. Wan
• Laparoscopic para- aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2–IIIB (1 July, 2008)

  D. G. Mortier, S. Stroobants, F. Amant, P. Neven, E. Van Limbergen, I. Vergote
• Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma (1 July, 2008)

  C. J. Darus, M. B. Callahan, Q.-N. Nguyen, L. M. Pastore, B. F. Schneider, L. W. Rice, A. A. Jazaeri
• One- year follow- up of single- visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand (1 July, 2008)

  B. Chumworathayi, S. Srisupundit, P. Lumbiganon, K. K. Limpaphayom
• The psychosocial impact of human papillomavirus testing in primary cervical screening— a study within a randomized trial (1 July, 2008)

  H. C. Kitchener, I. Fletcher, C. Roberts, P. Wheeler, M. Almonte, P. Maguire
• Absence of epidermal growth factor receptor mutations in cervical cancer (1 July, 2008)

  H. Arias-Pulido, N. Joste, A. Chavez, C. Y. Muller, D. Dai, H. O. Smith, C. F. Verschraegen
• Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer (1 July, 2008)

  Y. Huang, M.-N. Huang, N. Li, X.-G. Li, L.-Y. Wu
• The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon (1 July, 2008)

  P.-M. Tebeu, A. L. Major, E. Rapiti, P. Petignat, C. Bouchardy, Z. Sando, L. De Bernis, L. Ali, P. Mhawech-Fauceglia
• Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer (1 July, 2008)

  D. Fischerova, D. Cibula, H. Stenhova, H. Vondrichova, P. Calda, M. Zikan, P. Freitag, J. Slama, P. Dundr, J. Belacek
• Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study (1 July, 2008)

  K. Y. Look, J. A. Blessing, C. M. Michener, S. C. Rubin, P. T. Ramirez
• Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases (1 July, 2008)

  X. Cheng, S. M. Cai, Z. T. Li, X. H. Wu, Y. Q. Ding, X. E. Wang, R. Y. Zang
• Analysis of human papillomavirus and Epstein- Barr virus infection and aberrant death- associated protein kinase methylation in high- grade squamous intraepithelial lesions (1 July, 2008)

  F. Lattario, Y. L. Furtado, R. Fonseca, F. A. Silveira, I. C. Do Val, G. Almeida, M. G.C. Carvalho
• Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters (1 July, 2008)

  N. Kapucuoglu, D. Bulbul, G. Tulunay, M. A. Temel
• Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population (1 July, 2008)

  R. Berretta, C. Merisio, M. Melpignano, M. Rolla, M. Ceccaroni, A. De Ioris, T. S. Patrelli, G. B. Nardelli
• Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel— long- term follow- up (1 July, 2008)

  B. Sorbe, H. Andersson, K. Boman, P. Rosenberg, M. Kalling
• Determining predominating histologic component in malignant mixed mü llerian tumors: is it worth it? (1 July, 2008)

  M. Ozguroglu, A. Bilici, S. Ilvan, H. Turna, B. Atalay, N. Mandel, İ. ŞAhinler
• Does hysteroscopy affect prognosis in apparent early- stage endometrial cancer? (1 July, 2008)

  A. Ben-Arie, S. Tamir, S. Dubnik, O. Gemer, A. Ben Shushan, R. Dgani, G. Peer, O. Barnett-Griness, O. Lavie
• Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? (1 July, 2008)

  J. S. Kwon, J. Abrams, A. Sugimoto, M. S. Carey
• Prognostic factors for ovarian metastases from primary gastric cancer (1 July, 2008)

  J. Wang, Y.-K. Shi, L.-Y. Wu, J.-W. Wang, S. Yang, J.-L. Yang, H.-Z. Zhang, S.-M. Liu
• Ultrasound- guided tru- cut biopsy in the management of advanced abdomino- pelvic tumors (1 July, 2008)

  D. Fischerova, D. Cibula, P. Dundr, M. Zikan, P. Calda, P. Freitag, J. Slama